Teva Pharmaceutical Industries Limited TEVA.TA Stock
Teva Pharmaceutical Industries Limited Price Chart
Teva Pharmaceutical Industries Limited TEVA.TA Financial and Trading Overview
Contents
Teva Pharmaceutical Industries Limited stock price | 5075 ILA |
Previous Close | 2722 ILA |
Open | 2700 ILA |
Bid | 2673 ILA x 200 |
Ask | 2675 ILA x 34100 |
Day's Range | 2675 - 2736 ILA |
52 Week Range | 2383 - 3860 ILA |
Volume | 5.99M ILA |
Avg. Volume | 1.92M ILA |
Market Cap | 30.65B ILA |
Beta (5Y Monthly) | 1.180985 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.88 ILA |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | November 28, 2017 |
1y Target Est | N/A |
TEVA.TA Valuation Measures
Enterprise Value | 50.14B ILA |
Trailing P/E | N/A |
Forward P/E | 10.987951 |
PEG Ratio (5 yr expected) | 0.32 |
Price/Sales (ttm) | 2.0538974 |
Price/Book (mrq) | 390.0214 |
Enterprise Value/Revenue | 3.36 |
Enterprise Value/EBITDA | 13.251 |
Trading Information
Teva Pharmaceutical Industries Limited Stock Price History
Beta (5Y Monthly) | 1.180985 |
52-Week Change | 1.33% |
S&P500 52-Week Change | 20.43% |
52 Week High | 3860 ILA |
52 Week Low | 2383 ILA |
50-Day Moving Average | 3007.92 ILA |
200-Day Moving Average | 3180.15 ILA |
TEVA.TA Share Statistics
Avg. Volume (3 month) | 1.92M ILA |
Avg. Daily Volume (10-Days) | 1.94M ILA |
Shares Outstanding | 1.12B |
Float | 1.11B |
Short Ratio | N/A |
% Held by Insiders | 0.84% |
% Held by Institutions | 4.20% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -10.74% |
Operating Margin (ttm) | 16.71% |
Gross Margin | 45.66% |
EBITDA Margin | 25.35% |
Management Effectiveness
Return on Assets (ttm) | 3.44% |
Return on Equity (ttm) | -17.93% |
Income Statement
Revenue (ttm) | 14.92B ILA |
Revenue Per Share (ttm) | 13.42 ILA |
Quarterly Revenue Growth (yoy) | 0% |
Gross Profit (ttm) | 6.97B ILA |
EBITDA | 3.78B ILA |
Net Income Avi to Common (ttm) | -1603000064 ILA |
Diluted EPS (ttm) | -5.18 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 2.14B ILA |
Total Cash Per Share (mrq) | 1.91 ILA |
Total Debt (mrq) | 21.04B ILA |
Total Debt/Equity (mrq) | 244.29 ILA |
Current Ratio (mrq) | 1.105 |
Book Value Per Share (mrq) | 7.015 |
Cash Flow Statement
Operating Cash Flow (ttm) | 1.49B ILA |
Levered Free Cash Flow (ttm) | 2.62B ILA |
Profile of Teva Pharmaceutical Industries Limited
Country | Israel |
State | N/A |
City | Tel Aviv |
Address | 124 Dvora Hanevi’a Street |
ZIP | 6944020 |
Phone | 972 3 914 8213 |
Website | https://www.tevapharm.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 34004 |
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also manufactures and sells active pharmaceutical ingredients, as well as provides contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. In addition, it focuses on the central nervous system (CNS), pain, respiratory, and oncology areas. The company's products portfolio in the CNS field comprises Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; and AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; respiratory therapeutic area includes ProAir RespiClick, QVAR, ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease; and oncology therapeutic field consists of Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Q&A For Teva Pharmaceutical Industries Limited Stock
What is a current TEVA.TA stock price?
Teva Pharmaceutical Industries Limited TEVA.TA stock price today per share is 5075 ILA.
How to purchase Teva Pharmaceutical Industries Limited stock?
You can buy TEVA.TA shares on the Tel Aviv exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Teva Pharmaceutical Industries Limited?
The stock symbol or ticker of Teva Pharmaceutical Industries Limited is TEVA.TA.
Which industry does the Teva Pharmaceutical Industries Limited company belong to?
The Teva Pharmaceutical Industries Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Teva Pharmaceutical Industries Limited have in circulation?
The max supply of Teva Pharmaceutical Industries Limited shares is 11.51M.
What is Teva Pharmaceutical Industries Limited Price to Earnings Ratio (PE Ratio)?
Teva Pharmaceutical Industries Limited PE Ratio is now.
What was Teva Pharmaceutical Industries Limited earnings per share over the trailing 12 months (TTM)?
Teva Pharmaceutical Industries Limited EPS is -1.88 ILA over the trailing 12 months.
Which sector does the Teva Pharmaceutical Industries Limited company belong to?
The Teva Pharmaceutical Industries Limited sector is Healthcare.
Teva Pharmaceutical Industries Limited TEVA.TA included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
- {{ link.label }} {{link}}